Retail News Breaks Archives
Kerr Drug launches synchronized Rx refills
May 20th, 2013
RALEIGH, N.C. – Kerr Drug has introduced Simplify My Meds, a synchronized prescription refill service.
The North Carolina drug chain said Monday that Simplify My Meds leverages capabilities brought by the company's new central-fill facility in Raleigh and extends its menu of refill services.
To use Simplify My Meds, customers ask a Kerr pharmacist to enroll them and select a date each month that is convenient. Then on that date each month, all of their prescriptions will be ready for pickup at one time. Those participating in the program also get a free monthly consultation about their medications.
Kerr expects the service to eliminate extra trips for pharmacy patients as well as improve medication adherence and, in turn, customer loyalty.
"We have been moving beyond a simple dispensing model, which is critical in keeping pace with the changing retail pharmacy world, as well as how our patients interact with it," Kerr Drug chief executive officer Tony Civello said in a statement. "That is why we have already deployed programs like Auto Refill, Mobile App, text messaging and now Simplify My Meds. We must not only find technologies to maximize the utilization of our pharmacist resources, but also be reachable how and where where our customer needs us to be."
In opening the central-fill operation, Kerr leveraged its partnership with PDX and ScriptPro to capitalize on new technologies to raise pharmacy productivity, which frees up pharmacists to focus more on patient care. The chain has 80 stores.
"It's not just about labor savings, inventory reductions and other efficiencies. These kinds of innovations and use of technologies are critical to remaining a player in the emerging health care ecosystem," Civello said earlier this year. "Pharmacists will become a much larger part of the health care provider team, and central fill allows our pharmacists the time they need out front with the patients. We expect huge dividends in patient adherence as well as return on investment from the technology itself."